Fundamentals of Clinical Pharmacology With Application for Pregnant Women
- 12 May 2017
- journal article
- review article
- Published by Wiley in Journal of Midwifery & Women's Health
- Vol. 62 (3) , 298-307
- https://doi.org/10.1111/jmwh.12621
Abstract
Medication use is common in pregnancy, yet for most medications the optimal formulation and dosage have not been described specifically for pregnant women. Often, adverse effects are only discovered anecdotally or after extensive off-label use occurs. Since pharmacologic research that includes pregnant women is sparse and animal studies are often not applicable to the human fetus, providers must use knowledge of drug behavior and normal physiologic changes of pregnancy to personalize treatment for pregnant women. In this review, we present an overview of the basic concepts of clinical pharmacology: pharmacokinetics, pharmacodynamics, and pharmacogenomics. The normal physiologic changes of pregnancy are presented as a framework to understand alterations in drug behavior. A clinical vignette that addresses 4 pregnancy scenarios involving medications—preterm birth, vaccination, herpes simplex virus infection, and codeine toxicity—is provided to illustrate application of core clinical pharmacologic concepts. Discussion of relevant literature illustrates the challenges of offering individualized pharmacologic therapy in pregnancy.Keywords
This publication has 57 references indexed in Scilit:
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin DosingClinical Pharmacology & Therapeutics, 2011
- Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008American Journal of Obstetrics and Gynecology, 2011
- Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproateAmerican Journal of Obstetrics and Gynecology, 2011
- Influenza Vaccine Given to Pregnant Women Reduces Hospitalization Due to Influenza in Their InfantsClinical Infectious Diseases, 2010
- Can extremely low or high morphine formation from codeine be predicted prior to therapy initiation?Pain, 2009
- Effectiveness of Maternal Influenza Immunization in Mothers and InfantsNew England Journal of Medicine, 2008
- Long-Term Medical and Social Consequences of Preterm BirthNew England Journal of Medicine, 2008
- Seroprevalence of herpes simplex virus types 1 and 2 in pregnant women in the United StatesAmerican Journal of Obstetrics and Gynecology, 2007
- Emerging Infections and PregnancyEmerging Infectious Diseases, 2006
- Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI)Published by Elsevier ,2005